2seventy bio Inc (NASDAQ:TSVT) has a beta value of 1.60 and has seen 31.47 million shares traded in the last trading session. The company, currently valued at $255.37M, closed the last trade at $4.95 per share which meant it gained $2.15 on the day or 76.79% during that session. The TSVT stock price is -21.01% off its 52-week high price of $5.99 and 53.74% above the 52-week low of $2.29.
The consensus among analysts is that 2seventy bio Inc (TSVT) is Buy stock at the moment, with a recommendation rating of 3.50. 1 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 7 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.1.
2seventy bio Inc (NASDAQ:TSVT) trade information
Over the past 30 days, the shares of 2seventy bio Inc (NASDAQ:TSVT) have changed 115.22%.
Wall Street analysts have a consensus price target for the stock at $2, which means that the shares’ value could drop -147.5% from current levels. The projected low price target is $2.0 while the price target rests at a high of $2.0. In that case, then, we find that the current price level is 59.6% off the targeted high while a plunge would see the stock lose 59.6% from current levels.
2seventy bio Inc (TSVT) estimates and forecasts
The company’s shares have gained 12.50% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -48.74%.
3 analysts offering their estimates for the company have set an average revenue estimate of 13.03M for the current quarter. 3 have an estimated revenue figure of 13.96M for the next ending quarter. Year-ago sales stood 10.68M and 12.44M respectively for this quarter and the next, and analysts expect sales will grow by 22.00% for the current quarter and -48.74% for the next.
Earnings growth for 2025 is a modest 81.00% while over the next 5 years, the company’s earnings are expected to increase by 67.80%.
TSVT Dividends
2seventy bio Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
2seventy bio Inc (NASDAQ:TSVT)’s Major holders
The top two institutional holders are KYNAM CAPITAL MANAGEMENT, LP with over 5.95 million shares worth more than $22.92 million. As of 2024-06-30, KYNAM CAPITAL MANAGEMENT, LP held 11.4089% of shares outstanding.
The other major institutional holder is GOLDMAN SACHS GROUP INC, with the holding of over 4.14 million shares as of 2024-06-30. The firm’s total holdings are worth over $15.93 million and represent 7.9465% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . As of Dec 31, 2024 , the former fund manager holds about 2.96% shares in the company for having 1.53 shares of worth $7.55 million while later fund manager owns 1.36 shares of worth $6.72 million as of Dec 31, 2024 , which makes it owner of about 2.63% of company’s outstanding stock.
